Corcept Therapeutics (CORT) Net Margin (2012 - 2026)
Corcept Therapeutics (CORT) reported Net Margin of 18.92% for Q1 2026, down 3183.0% on a YoY basis from 0.61% in Q1 2025, and down 259.99% sequentially from 11.83% in Q4 2025.
Corcept Therapeutics (CORT) Net Margin (2012 - 2026) Analysis & Trends
Corcept Therapeutics (CORT) has 15 years of Net Margin data on file, last reported at 18.92% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin fell 3183.0% year-over-year to 18.92%; the trailing twelve-month figure through Mar 2026 stood at 6.07% (down 1326.0% YoY), and the FY2025 full-year result was 12.89%, down 781.0% from the prior year.
- Net Margin eased to 18.92% in Q1 2026, from 11.83% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 33.96% in Q3 2022 to a low of 18.92% in Q1 2026.
- A 5-year average of 17.8% and a median of 18.74% in 2024 frame the typical range for Net Margin.
- Across the five-year window, Net Margin soared 696 bps in 2023 and tumbled 3183 bps in 2026, its largest moves.
- Tracing CORT's Net Margin over 5 years: stood at 16.04% in 2022, then surged by 43 bps to 23.0% in 2023, then fell by 27 bps to 16.71% in 2024, then fell by 29 bps to 11.83% in 2025, then sank by 260 bps to 18.92% in 2026.
- Business Quant data shows CORT's Net Margin at 18.92% in Q1 2026, 11.83% in Q4 2025, and 9.32% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Corcept Therapeutics | 10.09 Bn | 9.76 Bn | 162.02 Mn | -18.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.92% |
| Dec 31, 2025 | 11.83% |
| Sep 30, 2025 | 9.32% |
| Jun 30, 2025 | 17.80% |
| Mar 31, 2025 | 12.90% |
| Dec 31, 2024 | 16.71% |
| Sep 30, 2024 | 25.58% |
| Jun 30, 2024 | 21.44% |
| Mar 31, 2024 | 18.74% |
| Dec 31, 2023 | 23.00% |
| Sep 30, 2023 | 25.22% |
| Jun 30, 2023 | 23.24% |
| Mar 31, 2023 | 14.96% |
| Dec 31, 2022 | 16.04% |
| Sep 30, 2022 | 33.96% |
| Jun 30, 2022 | 26.50% |
| Mar 31, 2022 | 24.33% |
| Dec 31, 2021 | 32.44% |
| Sep 30, 2021 | 31.70% |
| Jun 30, 2021 | 28.96% |